Sangamo Therapeutics
Price & Volume
Stats
See more52W Range | $0.38-$2.84 |
Market Cap | $142.4M |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $32.8M |
Revenue Growth (YoY) | -98.8% |
Gross Profit (12 Mos) | -$72M |
Diluted EPS | -$0.45 |
News
See moreYahoo Finance • 2 days ago
Sector Update: Health Care Stocks Gain Friday Afternoon
Yahoo Finance • 2 days ago
Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease
Yahoo Finance • 17 days ago
Sangamo targets Q1 2026 BLA submission for Fabry gene therapy as FDA affirms accelerated pathway
Yahoo Finance • 17 days ago
Sangamo Therapeutics GAAP EPS of -$0.11 misses by $0.11, revenue of $0.6M misses by $33.8M
About
CEO | Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D. |
Address | 501 Canal Blvd, Richmond, CA, United States, 94804 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 183 |
